A D Hess|P N Colombani - JoVE Visualize

Showing results (61-70 of 93) with videos related to

Pageof 10

Sort By:

Transplantation|October 1, 1981

Suppressor cells in transplantation tolerance. II. maturation of suppressor cells in the bone marrow chimeraP J Tutschka, P F Ki, W E Beschorner, et al.

Journal of the European Academy of Dermatology and Venereology : JEADV|November 1, 2013

Genetic markers associated with progression in early mycosis fungoidesV E Johnson, E C Vonderheid, A D Hess, et al.

Journal of Immunology (Baltimore, Md. : 1950)|November 15, 1988

Activation of human T lymphocytes by bryostatinA D Hess, M K Silanskis, A H Esa, et al.

Transplantation|October 11, 1991

Prevention of syngeneic graft-versus-host disease by recovery of thymic microenvironment after cyclosporineW E Beschorner, H Ren, J Phillips, et al.

Transplantation|April 1, 1988

Cyclosporine-induced cell-mediated injury of the thymic medullary epitheliumW E Beschorner, J L Olson, A D Hess, et al.

British Journal of Haematology|September 1, 1982

4-hydroperoxycyclophosphamide: a model for eliminating residual human tumour cells and T-lymphocytes from the bone marrow graftM Körbling, A D Hess, P J Tutschka, et al.

Experimental Hematology|October 1, 1980

Plasmapheresis as immunotherapeutic modality in the treatment of the canine venereal tumorA R Zander, S Sarpell, B Cunningham, et al.

Cancer Research|January 15, 1991

Successful treatment of murine melanoma with bryostatin 1L M Schuchter, A H Esa, S May, et al.

Proceedings of the National Academy of Sciences of the United States of America|October 1, 1987

Calcium and calmodulin antagonists inhibit human malaria parasites (Plasmodium falciparum): implications for drug designL W Scheibel, P M Colombani, A D Hess, et al.

Blood|March 15, 1997

Specificity of effector T lymphocytes in autologous graft-versus-host disease: role of the major histocompatibility complex class II invariant chain peptideA D Hess, E C Bright, C Thoburn, et al.

Pageof 10

Showing results (61-70 of 93) with videos related to

Sort By:

Pageof 10

Transplantation|October 1, 1981

Suppressor cells in transplantation tolerance. II. maturation of suppressor cells in the bone marrow chimeraP J Tutschka, P F Ki, W E Beschorner, et al.

Journal of the European Academy of Dermatology and Venereology : JEADV|November 1, 2013

Genetic markers associated with progression in early mycosis fungoidesV E Johnson, E C Vonderheid, A D Hess, et al.

Journal of Immunology (Baltimore, Md. : 1950)|November 15, 1988

Activation of human T lymphocytes by bryostatinA D Hess, M K Silanskis, A H Esa, et al.

Transplantation|October 11, 1991

Prevention of syngeneic graft-versus-host disease by recovery of thymic microenvironment after cyclosporineW E Beschorner, H Ren, J Phillips, et al.

Transplantation|April 1, 1988

Cyclosporine-induced cell-mediated injury of the thymic medullary epitheliumW E Beschorner, J L Olson, A D Hess, et al.

British Journal of Haematology|September 1, 1982

4-hydroperoxycyclophosphamide: a model for eliminating residual human tumour cells and T-lymphocytes from the bone marrow graftM Körbling, A D Hess, P J Tutschka, et al.

Experimental Hematology|October 1, 1980

Plasmapheresis as immunotherapeutic modality in the treatment of the canine venereal tumorA R Zander, S Sarpell, B Cunningham, et al.

Cancer Research|January 15, 1991

Successful treatment of murine melanoma with bryostatin 1L M Schuchter, A H Esa, S May, et al.

Proceedings of the National Academy of Sciences of the United States of America|October 1, 1987

Calcium and calmodulin antagonists inhibit human malaria parasites (Plasmodium falciparum): implications for drug designL W Scheibel, P M Colombani, A D Hess, et al.

Blood|March 15, 1997

Specificity of effector T lymphocytes in autologous graft-versus-host disease: role of the major histocompatibility complex class II invariant chain peptideA D Hess, E C Bright, C Thoburn, et al.

Pageof 10